JACKSONVILLE, Fla. March 2, 2015 – Healogics, Inc., the nation’s largest provider of advanced wound care services announced today that it has completed the acquisition of Accelecare Wound Centers, Inc., also a leading provider of wound care services.
“This transaction makes tremendous sense for the employees and hospital partners of both companies, and most importantly, the growing population of patients with chronic wounds,” said Jeff Nelson, president and chief executive officer for Healogics. “Combining the two premier wound management companies will allow us to invest in the further development of the advanced wound care market. Both companies have invested in physician services businesses in the last few years, creating opportunities for physicians to engage in wound care full time. There are significant opportunities to raise market awareness. With the data we collect on the large number of wounds treated, we determine the most effective treatment pathways for our patients and share them across our provider base.”
Michael Lester, chairman and chief executive officer of Accelecare said, “This combination will leverage Healogics and Accelecare’s strengths including talented team members, an extensive network of wound care physicians, advanced training opportunities and an innovative wound care technology platform.”
Nelson went on to say, “Healogics and Accelecare share a passion for patient care and commitment to quality. We believe this acquisition moves us one step closer to achieving our mission to reach and heal more patients wherever they may be, by the best means available.”
Headquartered in Jacksonville, FL., Healogics is the nation’s largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 600 Wound Care Centers® in the nation and saw more than 234,000 patients in 2014 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post‐acute sites. Healogics utilizes an evidence‐based systematic approach to chronic wound healing to treat an underserved and growing patient population. A fund managed by Clayton, Dubilier & Rice, a private investment firm, is the majority shareholder of Healogics. For more information, please visit www.healogics.com.
About Accelecare Wound Centers
Accelecare Would Centers is a comprehensive wound care and disease management company.
Accelecare provides full service wound management solutions to hospitals and related health care
organizations across the United States. The company offers state of the art Advanced Wound Centers staffed with trained physicians, nurses, and specialized technicians providing efficacious and cost effective wound treatments ensuring positive outcomes. Accelecare’s mission is centered around partnering with hospitals in order to provide patient care with the highest level of clinical excellence. Revelstoke Capital Partners and its institutional co‐investors, are the majority shareholders of Accelecare.